Uniti Solutions Launches Managed AI Security to Help Businesses Combat AI Cyber Risks Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2022
Initiated EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis Described new understanding…
AviadoBio to Present Pre-clinical Data on its Gene Therapy Candidate for Frontotemporal Dementia at ASGCT 2022
AviadoBio to Present Pre-clinical Data on its Gene Therapy Candidate for Frontotemporal Dementia at ASGCT…
Immunovant to Present at LifeSci Partners’ Immunology and Inflammation Symposium on May 10th
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
Synthetic Biologics Announces Presentation on VCN-11, a Novel Oncolytic Adenovirus Designed to Evade Neutralizing Antibodies at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
– VCN-11 incorporates a proprietary albumin binding domain in the virus shell with the potential…
Positive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
– Data reconfirm previously highlighted safety and efficacy potential of AGTC-501 as a treatment for…
Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions
BURBANK, CA, May 04, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
Aadi Bioscience Announces Unique Permanent J-code Issued for FYARRO™ from Centers for Medicare and Medicaid Services
J-Code, Effective July 1st, Will Enable a Streamlined Reimbursement Process for FYARRO™ LOS ANGELES, May…
Vericel Reports First Quarter 2022 Financial Results
First Quarter Total Net Revenue of $36.1 Million Conference Call Today at 8:30am Eastern Time…
EyePoint Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Developments
– Presented positive eight-month safety and efficacy data from ongoing DAVIO Phase 1 clinical trial…
Mindset Pharma to Participate in Upcoming Conferences in May 2022
TORONTO, May 04, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme
No dose limiting toxicity observed in previous three dose level cohortsRepresents a 50% higher dose…
Aptose Receives Fast Track Designation for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation
SAN DIEGO and TORONTO, May 04, 2022 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…
Abeona Therapeutics Announces AAV204, a Novel AAV Capsid, Demonstrated Robust Macular Transduction Following Para-Retinal Administration in Non-Human Primates
NEW YORK and CLEVELAND, Ohio, May 04, 2022 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq:…
Diffusion Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements
CHARLOTTESVILLE, Va., May 04, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or…
Harvard Bioscience Announces First Quarter 2022 Financial Results
• Revenue up 7% year-over-year despite volatility in China related to COVID-19 and global…
Akouos to Present at Bank of America 2022 Healthcare Conference
BOSTON, May 04, 2022 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic…
Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates
Additional clinical data from ONCR-177 surface lesion monotherapy expansion and combination expansion cohorts expected in…
ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022
Conference Call Scheduled for May 11, 2022 at 4:30 p.m. ET RAMSEY, N.J. and BOCA…
Amicus Therapeutics to Present at the Bank of America 2022 Healthcare Conference
PHILADELPHIA, May 04, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management…
EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan
– Betta Pharmaceuticals to develop and commercialize EYP-1901 in China, Hong Kong, Macau and Taiwan;…